Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis

• Verfasst von: Mohs, Antje [VerfasserIn]
• Verfasst von: Otto, Tobias [VerfasserIn]
• Verfasst von: Schneider, Kai Markus [VerfasserIn]
• Verfasst von: Peltzer, Mona [VerfasserIn]
• Verfasst von: Boekschoten, Mark [VerfasserIn]
• Verfasst von: Holland, Christian H. [VerfasserIn]
• Verfasst von: Hudert, Christian A. [VerfasserIn]
• Verfasst von: Kalveram, Laura [VerfasserIn]
• Verfasst von: Wiegand, Susanna [VerfasserIn]
• Verfasst von: Sáez Rodríguez, Julio [VerfasserIn]
• Verfasst von: Longerich, Thomas [VerfasserIn]
• Verfasst von: Hengstler, Jan G. [VerfasserIn]
• Verfasst von: Trautwein, Christian [VerfasserIn]
• Titel: Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis
• Verf.angabe: Antje Mohs, Tobias Otto, Kai Markus Schneider, Mona Peltzer, Mark Boekschoten, Christian H. Holland, Christian A. Hudert, Laura Kalveram, Susanna Wiegand, Julio Saez-Rodriguez, Thomas Longerich, Jan G. Hengstler, Christian Trautwein
• Jahr: 2021
• Umfang: 11 S.
• Fussnoten: Available online 24 October 2020 ; Gesehen am 02.09.2021
• Titel Quelle: Enthalten in: Journal of hepatology
• Ort Quelle: Amsterdam [u.a.] : Elsevier Science, 1985
• Jahr Quelle: 2021
• Band/Heft Quelle: 74(2021), 3, Seite 638-648
• ISSN Quelle: 1600-0641
• DOI: doi:10.1016/j.jhep.2020.09.037
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Chronic liver disease
• Sach-SW: KEAP1
• Sach-SW: NASH
• Sach-SW: NRF2
• Sach-SW: oxidative stress
• K10plus-PPN: 175353268X

Abstract

Background & Aims - In chronic liver diseases, inflammation induces oxidative stress and thus may contribute to the progression of liver injury, fibrosis, and carcinogenesis. The KEAP1/NRF2 axis is a major regulator of cellular redox balance. In the present study, we investigated whether the KEAP1/NRF2 system is involved in liver disease progression in humans and mice. - Methods - The clinical relevance of oxidative stress was investigated by liver RNA sequencing in a well-characterized cohort of patients with non-alcoholic fatty liver disease (n = 63) and correlated with histological and clinical parameters. For functional analysis, hepatocyte-specific Nemo knockout (NEMOΔhepa) mice were crossed with hepatocyte-specific Keap1 knockout (KEAP1Δhepa) mice. - Results - Immunohistochemical analysis of human liver sections showed increased oxidative stress and high NRF2 expression in patients with chronic liver disease. RNA sequencing of liver samples in a human pediatric NAFLD cohort revealed a significant increase of NRF2 activation correlating with the grade of inflammation, but not with the grade of steatosis, which could be confirmed in a second adult NASH cohort. In mice, microarray analysis revealed that Keap1 deletion induces NRF2 target genes involved in glutathione metabolism and xenobiotic stress (e.g., Nqo1). Furthermore, deficiency of one of the most important antioxidants, glutathione (GSH), in NEMOΔhepa livers was rescued after deleting Keap1. As a consequence, NEMOΔhepa/KEAP1Δhepa livers showed reduced apoptosis compared to NEMOΔhepa livers as well as a dramatic downregulation of genes involved in cell cycle regulation and DNA replication. Consequently, NEMOΔhepa/KEAP1Δhepa compared to NEMOΔhepa livers displayed decreased fibrogenesis, lower tumor incidence, reduced tumor number, and decreased tumor size. - Conclusions - NRF2 activation in patients with non-alcoholic steatohepatitis correlates with the grade of inflammation, but not steatosis. Functional analysis in mice demonstrated that NRF2 activation in chronic liver disease is protective by ameliorating fibrogenesis, initiation and progression of hepatocellular carcinogenesis. - Lay summary - The KEAP1 (Kelch-like ECH-associated protein-1)/NRF2 (erythroid 2-related factor 2) axis has a major role in regulating cellular redox balance. Herein, we show that NRF2 activity correlates with the grade of inflammation in patients with non-alcoholic steatohepatitis. Functional studies in mice actually show that NRF2 activation, resulting from KEAP1 deletion, protects against fibrosis and cancer.